Cargando…
Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection
The characteristics of COVID-19 patients with persistent SARS-CoV-2 infection are not yet well described. Here, we compare the clinical and molecular features of patients with long duration of viral shedding (LDs) with those from patients with short duration patients (SDs), and healthy donors (HDs)....
Autores principales: | Yang, Bin, Fan, Junpeng, Huang, Jia, Guo, Ensong, Fu, Yu, Liu, Si, Xiao, Rourou, Liu, Chen, Lu, Funian, Qin, Tianyu, He, Chao, Wang, Zizhuo, Qin, Xu, Hu, Dianxing, You, Lixin, Li, Xi, Wang, Tian, Wu, Peng, Chen, Gang, Zhou, Jianfeng, Li, Kezhen, Sun, Chaoyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190301/ https://www.ncbi.nlm.nih.gov/pubmed/34108465 http://dx.doi.org/10.1038/s41467-021-23621-y |
Ejemplares similares
-
Impact of chemotherapy and immunotherapy on the composition and function of immune cells in COVID-19 convalescent with gynecological tumors
por: Qin, Tianyu, et al.
Publicado: (2021) -
Mutation profiles in circulating cell‐free DNA predict acquired resistance to olaparib in high‐grade serous ovarian carcinoma
por: Hu, Dianxing, et al.
Publicado: (2022) -
The Immunological Role of CDK4/6 and Potential Mechanism Exploration in Ovarian Cancer
por: Liu, Chen, et al.
Publicado: (2022) -
Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis
por: Yang, Bin, et al.
Publicado: (2022) -
BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumors
por: Fu, Yu, et al.
Publicado: (2023)